Litcius/Paper detail

Harmine-based dual inhibitors targeting histone deacetylase (HDAC) and DNA as a promising strategy for cancer therapy

Dehua Lu, Lailiang Qu, Cheng Wang, Heng Luo, Shang Li, Fucheng Yin, Xingchen Liu, Xinye Chen, Zhongwen Luo, Ningjie Cui, Peng Wan, Limei Ji, Lingyi Kong, Xiaobing Wang

2022Bioorganic Chemistry22 citationsDOI

Topics & Concepts

HarmineHistone deacetylaseDNA damageChemistryHDAC1HistoneAcetylationDNACancer researchHDAC6PharmacologyBiochemistryBiologyGeneSynthesis and bioactivity of alkaloidsSynthesis and pharmacology of benzodiazepine derivativesCancer therapeutics and mechanisms
Harmine-based dual inhibitors targeting histone deacetylase (HDAC) and DNA as a promising strategy for cancer therapy | Litcius